Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
|
|
Boston Globe (12.23.01) - Thursday, December 27, 2001
"...All of this makes it more urgent than ever for public health officials and AIDS activists to stress prevention for high-risk individuals.
"...The research should also move elected officials in Massachusetts who have balked at letting the state Department of Public Health set up needle-exchange programs in cities with high rates of injection drug use. In Boston, Cambridge, Northampton, and Provincetown, which have such programs, the spread of the virus has been reduced without encouraging more drug abuse. But in cities like New Bedford and Springfield, which lack needle exchanges, contaminated drug syringes are the single biggest cause of new AIDS infections.
"Nationally, the evidence of increasing resistance should spur efforts by the Centers for Disease Control and Prevention to encourage biomedical companies to bring fast and reliable AIDS tests to market. Such tests... are available overseas. But according to the Wall Street Journal, one company here has blocked the introduction of the new tests in the United States to protect its own slower tests.
"Dr. Anthony Fauci of the National Institute of Allergy and Infectious Diseases said last week that the new data point up the need to develop new AIDS drugs that doctors can prescribe for patients when they see the benefits of older ones fading. Scientists also hope one day to develop an effective vaccine against the disease. In the meantime, though, the focus must be on prevention, using all the practical and readily available means for stopping the transmission of this dreaded disease."
011227
AD012242
Copyright © 2001 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.